Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for January 2010
January 5, 2010
- Dr. Reddy's and Rheoscience Announce Headline Results from First Phase III Clinical Trial of Balaglitazone (DRF 2593)
- Fifteen Percent of ADXS11-001 Treated Cervix Cancer Patients Still Alive Three Years after Initial Dosing
- Akebia Announces Positive AKB-6548 Phase 1 Clinical Study
January 6, 2010
- Pearl Therapeutics Announces Positive Results from Phase 2a Trial of Glycopyrrolate Inhalation Aerosol in Chronic Obstructive Pulmonary Disease
- Pearl Therapeutics Announces Positive Results From Phase 2a Trial of Formoterol Inhalation Aerosol in Chronic Obstructive Pulmonary Disease
- Phase II Clinical Trial of Gilead's Investigational Integrase-Based, Once-Daily, Fixed-Dose ?Quad? Regimen Meets 24-Week Primary Objective
- Biofrontera AG (de) - Detailed phase III results confirm superiority of BF-200 ALA over Metvix
January 7, 2010
- Almirall and Forest announce positive results from the ACCORD COPD I Phase III study of aclidinium bromide in Chronic Obstructive Pulmonary Disease (COPD)
- Successful Phase 3 data for Biofrontera in the treatment of Actinic Keratosis
- Immutep Announces Final Results In Phase I/II Chemoimmunotherapy Trial In Breast Cancer
- Elsevier's "Article of the Future" is now Available for all Cell Press Journals
- VIVUS Announces Positive Results From Phase 2 Study of Qnexa in Obstructive Sleep Apnea
- Ardea Biosciences Reports Positive Results for RDEA594, its Lead Product Candidate for Gout, in Combination with Allopurinol or Febuxostat
January 8, 2010
- Presidio Pharmaceuticals, Inc. to Present at the Biotech Showcase 2010
- Provectus Pharmaceuticals Reports to Shareholders on 2009 Accomplishments and Clinical Development Plans
- NeoPharm Presents the Phase II Data of Liposome-Entrapped Paclitaxel (LEP) in Patients with Metastatic Breast Cancer
- Geron Announces Publication of Data on Its Telomerase Inhibitor in Glioblastoma
January 11, 2010
- Achillion Announces Additional Positive Phase 1b Data With ACH-1625 to Treat Hepatitis C
- Alligator Bioscience AB (se) - Alligator Bioscience´s protein drug candidate ADC-1004 for treatment of ischemia reperfusion (I/R) injury reduced myocardial infarct size in a porcine model
- Antares Pharma And Population Council Announce Positive Phase 2 Trial Results
- Protox announces positive Phase 2b BPH results
January 12, 2010
- M. D. Anderson News Release: Growth Factor Hit by Cancer Drugs also Protects Heart
- Two New Studies Show Gallium-Containing Compounds Significantly Increase Bone Strength in Standard Models of Osteoporosis
- Nektar Therapeutics Announces Positive Topline Results for NKTR-102 From First Stage of Phase 2 Study in Platinum-Resistant Ovarian Cancer
January 13, 2010
- Raptor Pharmaceutical Corp. Announces Publication of Results from Phase 2a Trial of DR Cysteamine for Treatment of Cystinosis
- MedPage Today 'What Your Physicians Are Reading'
- Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
January 14, 2010
- STELARA Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine
- Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
- Stelara Shows Greater Efficacy than Etanercept for Treatment Of Moderate-To-Severe Plaque Psoriasis
- KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP106 for ADHD
- Pluristem Therapeutics Announces Interim Results from PLX-PAD Clinical Trials
- Symphogen Publishes Pre-Clinical Data in Cancer Research Demonstrating Superior Efficacy of Anti?EGFR Monoclonal Antibody Combination Sym004
- InVasc Therapeutics to Present at Biotech Showcase 2010 and Announces Domain Name Change
- Majestic Research Finds Hematologists/Oncologists Expect to Change Multiple Myeloma Treatment Practices Due to ASH 2009 Data
- Cerus Corporation Reports Positive Outcome in European Study of 7-Day INTERCEPT Platelets
January 15, 2010
January 19, 2010
- DURECT Initiates U.S. Pivotal Phase III POSIDUR Clinical Trial
- Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 1 Safety Trial of SB-728-T for HIV/AIDS
- RXi Pharmaceuticals Presented New Pre-Clinical Data at the Keystone RNAi Silencing Conference
- NERI Research Findings Show that Erectile Dysfunction May be Early Warning of Future Cardiovascular Disease
- Synta Presents Results at AACR-IASLC Demonstrating Potent and Synergistic Activity of STA-9090 in NSCLC Cell Lines Including Mutated EGFR, HER2, and KRAS
- Two New Studies Show Gallium-Containing Compounds Significantly Increase Bone Strength in Standard Models of Osteoporosis
January 20, 2010
- MedPage Today 'What Your Physicians Are Reading'
- Cholesterol-Lowering Drug Shows Promise Against Serious Infections in Sickle Cell Disease
- Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
- New Study Shows ImmunoCellular Therapeutics' Lead Investigational Cancer Vaccine ICT-107 Targets Cancer Stem Cells
- ARCA Announces Publication of Bucindolol Data in Circulation: Heart Failure
- Access Pharmaceutical's Cobalamin Oral Insulin Achieves Greater Than 80% Oral Bioavailability In Preclinical Models
- Study Results Evaluating the Correction of Atrophic Scars with Artefill Presented at 2010 Orlando Dermatology Conference
January 21, 2010
- Alnylam and Collaborators Present Data from Multiple Pre-Clinical and Clinical Programs at RNAi Keystone Symposium
- Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
- Novartis International AG (CH) - Novartis oral MS therapy FTY720 shows reduced risk of confirmed disability progression as published in New England Journal of Medicine
- Inspire Announces Results of Phase 3 PROLACRIA Trial for Dry Eye
- Two-Year Results From CLARITY Study with Cladribine Tablets in Multiple Sclerosis Published in The New England Journal of Medicine
- ICU Director - New Journal Launched By SAGE
- Galapagos NV (BE) - Galapagos candidate metastasis drug shows good safety and biomarker response
- Amgen Presents Complete Results From Two Pivotal Phase 3 Studies of Vectibix(R) at Gastrointestinal Cancers Symposium
- AEterna Zentaris Partner, Keryx Biopharmaceuticals, to Present Poster Highlighting Clinical Activity of Perifosine (KRX-0401) at the ASCO 2010 Gastrointestinal Cancers Symposium
- Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the ASCO 2010 Gastrointestinal Cancers Symposium
January 25, 2010
January 27, 2010
- Bavarian Nordic A/S (DK) - Prostvac paper published in Journal of Clinical Oncology
- Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infection
January 28, 2010
January 29, 2010
- Data Show Progression-Free Survival Advantage With Sutent® In Patients With Pancreatic Neuroendocrine Tumors
- Overcoming Taxane Resistance in Cancer
- AEterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer
- Supernus Announces Positive Results from Phase IIa Clinical Trial for SPN 810 in Children with ADHD and Serious Conduct Problems
- Anacor to Present Preclinical Data on Orally Active PDE4 Inhibitor at the 8th Cytokines and Inflammation Conference
- GENFIT: GFT505 Positioned as a Leading Drug Candidate in its Therapeutic Area
- Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics'
- Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results of Perifosine as a Single Agent for the Treatment of Advanced Waldenstrom's Macroglobulinemia
- New Article: Non-Patch, Transdermal Estrogen Products Such as Divigel Are Effective Hormone Therapy Alternatives to Oral Estrogen
- NewsRx Publishes Encyclopedia of Vaccines, 2009: An encyK Resource for Parents, Patients & Professionals
